GlassScriptPhysician profile
Robert Edward Clemency III
NPI 1508127663
$215,231.27
in general payments reported to CMS, 2019-2025
14 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $14K · 2021: $11K · 2022: $23K · 2023: $34K · 2024: $79K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Consulting Fee: $56K · Travel and Lodging: $13K · Honoraria: $10K · Food and Beverage: $4,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71,515.50 |
| Consulting Fee | $56,310.00 |
| Travel and Lodging | $12,590.24 |
| Honoraria | $10,000.00 |
| Food and Beverage | $4,185.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $197,303.48 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Smith+Nephew, INC. | $16,916.08 | 2019-2024 | Grafix Pl |
| Integra Lifesciences Corporation | $423.90 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $320.27 | 2019-2024 | Actishield Cf |
| Orthofix Medical, INC. | $82.48 | 2019-2025 | Physio-Stim |
| Polarityte, INC. | $27.79 | 2019 | |
| Wright Medical Technology, INC. | $24.90 | 2019 | |
| Polynovo North America LLC | $23.17 | 2024 | Novosorb Btm |
| Hartmann USA, INC. | $23.09 | 2025 | Zetuvit Plus 10x10 P10 |
| Treace Medical Concepts, INC. | $22.05 | 2024 | |
| Trice Medical, INC. | $19.02 | 2019 | |
| Depuy Synthes Sales INC. | $18.07 | 2021 | |
| Kerecis Limited | $13.51 | 2022 | |
| Sebela Pharmaceuticals INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clemency III listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.